JACK SU to High-Throughput Nucleotide Sequencing
This is a "connection" page, showing publications JACK SU has written about High-Throughput Nucleotide Sequencing.
Connection Strength
0.031
-
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03). J Clin Oncol. 2021 03 01; 39(7):822-835.
Score: 0.031